Condividi
Facebook
Linkedin
Twitter
StampaTaxon Name
Prototheca blaschkeae Roesler, Möller, Hendel, Baumann & Truyen
Accession number
9248
Form of supply
Agar
Restrictions on use
For commercial development a special agreement is requested
Nagoya protocol compliance conditions
Not under the scope of the CBD and the Nagoya protocol
Risk Group
1
GMO
No
Isolation source
individual mastitis milk
Isolation Locality
BEL – Belgium
Received from
Lagneau – Regional Veterinary Laboratory, Mons, Belgium
Date of deposit
01/01/2001
Other sequences
Prototheca_blaschkeae_DBVPG9248_cytb
CTTTTATTGTTGTATATTCTCATATGTTTAGAGGTTTATATTTTTCAAGTTATTCTAGTC
CACGTGAATTAACATGGATTGCTGGTGTAGCTATTTTATTATTAATGATTATTACTGCAT
TCATTGGTTACGTTTTACCTTGGGGTCAAATGAGTTTCTGGGGTGCTACAGTAATTACTA
GTTTAGCTAGTGCTATTCCTGTAGTTGGTAATAGTATTGTAACTTGGTTATGGGGAGGTT
TCTCTATTGACAATGCGACGTTAAATCGTTTTTTTAGTTTACATTATTTATTACCTTTCG
TAATTGCAGGTTTATCAATTGTACATATTGCAGCATTACATCAATATGGTTCAAATAACC
CATTAGGTATTAATTCAAAAACGGATAAAATTTCTTTTTATCCTTATTTTTATGTAAAAG
ATTTATTCGGATGGACTGTTTTTGCATTCTTCTTTGCATATTTTATTTATTATAATCCTA
ACCTTTTAGGTCATCCAGATAACTATATTCCTGCAAATCCTATGTCAACTCCAGCTCATA
TTGTACC
Recommended growth temperature
30°C
Recommended growth medium
PIM (Prototheca isolation medium) – YPDA (Yeast Extract Peptone Glucose Agar)
References
Buzzini et al.. Large-scale screening of the in vitro susceptibility of
Prototheca zopfii towards polyene antibiotics. Med.Mycol. (2008), 46: 511-514 DOI: 10.1080/13693780801993611
Richiedi informazioni
Inserisci i tuoi dati per ricevere informazioni su questo lievito